Unlock instant, AI-driven research and patent intelligence for your innovation.

Polypeptide, vaccine composed of polypeptide and application of polypeptide

A technology of vaccines and recombinant vectors, applied in the biological field, can solve side effects and other problems, achieve the effects of reducing senile plaques and Aβ levels, improving cognitive function damage, and good prospects for the treatment of AD

Active Publication Date: 2017-09-01
INST OF PROCESS ENG CHINESE ACAD OF SCI
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Moreover, targeting Aβ and APP with normal physiological functions can lead to side effects that can partially or completely counteract the therapeutic effect of antibodies or vaccines

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Polypeptide, vaccine composed of polypeptide and application of polypeptide
  • Polypeptide, vaccine composed of polypeptide and application of polypeptide
  • Polypeptide, vaccine composed of polypeptide and application of polypeptide

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] The preparation of embodiment 1 polypeptide

[0043] (1) Insert the AOE1 epitope polypeptide into the C-terminus of the Aga2 protein for whole gene synthesis, wherein the gene of the Aβ1-15 fragment is used as a positive control, and the pCTCON2 empty vector is used as a negative control;

[0044] The nucleic acid sequence of the AOE1 epitope polypeptide is shown in SEQ ID NO.2, and the nucleic acid sequence shown in SEQ ID NO.2 is as follows:

[0045] SEQ ID NO.2:

[0046] CGT CCG GAT CAG GTG ATG TGG GAT AGC AAA CGT CCG

[0047] The pCTCON2 plasmid was then digested with NdeI and XhoI, and the digested vector pCTCON2 was fused with the AOE1 epitope polypeptide to obtain a recombinant vector.

Embodiment 2

[0048] The preparation of embodiment 2 polypeptide

[0049] Compared with Example 1, except that the copy number of the AOE1 epitope polypeptide is increased, and the copy number of the AOE1 epitope polypeptide is 7, other conditions are the same as Example 1.

[0050] The effect of the prepared polypeptide is similar to that of Example 1, and subsequent experiments were carried out using the polypeptide prepared in Example 1.

Embodiment 3

[0051] The preparation of embodiment 3 vaccines

[0052] (1) Preparation of yeast competent cells

[0053] Saccharomyces cerevisiae EBY100 was inoculated in 50mL YPD liquid medium at a ratio of 1:100, cultured with shaking at 30°C and 260rpm for 4-6h to the pre-logarithmic phase; centrifuged at 6000rpm at room temperature for 10min; discarded the supernatant and resuspended with 25mL of resuspension buffer, transferred Put it into a 250mL shake flask, shake it at 30°C for 10min; centrifuge at 6000rpm at room temperature for 10min, discard the supernatant; resuspend in 25ml of sterile water, centrifuge at 6000rpm at room temperature for 10min, discard the supernatant; Competent cells;

[0054] (2) Yeast cell transformation and identification

[0055] Take 1 μL of the constructed expression plasmid and add it to 100 μL of yeast competent cells, incubate on ice for 5 min, and perform electroporation. Immediately after electroporation, 1 mL of YPD medium was added, transferred ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
thicknessaaaaaaaaaa
Login to View More

Abstract

The invention relates to a polypeptide, a vaccine composed of the polypeptide and application of the polypeptide. The polypeptide comprises an amino acid sequence shown as (a) and / or (b): (a) is the amino acid sequence shown as SEQ ID NO.1; (b) is a variant with the polypeptide function obtained by performing substitution, deletion or addition modification of one or more amino acid residues on the amino acid sequence shown as SEQ ID NO.1. The polypeptide disclosed by the invention is conformational simulation epitope of an Abeta42 oligomer, the antibody generated by immunization can specifically target pathogenic Abeta oligomers but is not bound to Abeta monomers and APP proteins. The autoimmunity problem of the Abeta vaccine can be effectively reduced. The polypeptide has excellent prospects for treating AD.

Description

technical field [0001] The invention relates to the field of biotechnology, in particular to a polypeptide, especially to a polypeptide and its composition vaccine and application. Background technique [0002] Alzheimer's disease (AD) is a neurodegenerative disease characterized by memory loss that seriously threatens the life and health of the elderly. The pathological features in the brain are mainly manifested by β-amyloid Aβ) senile plaques formed outside neuronal cells and neurofibrillary tangles formed inside neuronal cells by Tau protein. According to statistics, by the end of 2015, there were more than 46 million dementia patients in the world, and this number is expected to increase to 130 million by 2050. With the aging of the global population, the incidence and number of patients with AD have shown an increasing trend in recent years. However, there is currently no specific drug for the treatment of AD, so it is extremely urgent to develop drugs that can effec...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K7/08C12N15/81C12N1/19A61K39/00A61P25/28C12R1/865
CPCA61K39/0005A61K2039/523C07K7/08C12N15/81
Inventor 刘瑞田王少伟刘栋群
Owner INST OF PROCESS ENG CHINESE ACAD OF SCI